NCT03770832

Brief Summary

The objective of this study is to develop an automated, precise, quantitative assay for detecting atypical motor behavior and development in infants using data from wearable sensors and video recordings.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Mar 2019Dec 2026

First Submitted

Initial submission to the registry

December 6, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

March 29, 2019

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

7.7 years

First QC Date

December 6, 2018

Last Update Submit

January 16, 2026

Conditions

Keywords

Early DetectionWearable SensorsComputer Vision

Outcome Measures

Primary Outcomes (4)

  • Three month clinical score estimation

    Error between true clinical test scores and scores estimated from sensor and video data, assessed at the 3 month time-point.

    3 months

  • Six month clinical score estimation

    Error between true clinical test scores and scores estimated from sensor and video data, assessed at 6 month time-point.

    6 months

  • Prediction of neuromotor outcome using sensor and video data from 3 month time-point

    Sensitivity and specificity of algorithm (trained on sensor and video data from the 3 month time-point) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\])

    3 months

  • Prediction of neuromotor outcome using sensor and video data from 6 month time-point

    Sensitivity and specificity of algorithm (trained on sensor and video data from the 6 month time-point) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\])

    6 months

Secondary Outcomes (6)

  • Prediction of neuromotor outcome using General Movements Assessment (GMA) scores

    1-2 weeks, 1 month, 3 months

  • Prediction of neuromotor outcome using Alberta Infant Motor Scale (AIMS) scores

    6 months, 9 months, 1 year

  • Prediction of neuromotor outcome using Hammersmith Infant Neurological Examination (HINE) scores

    6 months, 9 months, 1 year

  • Prediction of neuromotor outcome using Test of Infant Motor Performance (TIMP) scores

    1-2 weeks, 1 month, 3 months

  • Clinical score estimation

    1-2 weeks, 1 month, 9 months, 1 year, 2 years

  • +1 more secondary outcomes

Other Outcomes (1)

  • Prediction of neuromotor outcome using NICU Network Neurobehavioral Scale (NNNS) scores

    1 month

Study Arms (2)

Infants at Risk for Atypical Motor Development (high-risk)

Infants Expected to Have Typical Motor Development (low-risk)

Eligibility Criteria

Age0 Months - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Individuals at high risk of developing motor delays \<24 months of age along with infants at low risk of developing motor delays.

You may qualify if:

  • Individuals identified as potentially at risk of abnormal motor development due to a risk factor (for example, prematurity, neonatal hypoxic ischemic encephalopathy, or neonatal stroke) OR control individuals for whom normal motor development is expected.
  • Age: \< 24 months of age
  • Legal guardian able and willing to give written consent and comply with study procedures.

You may not qualify if:

  • Any open wound or skin breakdown on the limbs or upper torso.
  • Missing or incomplete limbs (such as from amputation or congenital limb defects)
  • Legal guardian unable to give written consent and comply with study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Psychomotor DisordersNeurodevelopmental DisordersDevelopmental Disabilities

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Arun Jayaraman, PT, PhD

    Shirley Ryan AbilityLab

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 6, 2018

First Posted

December 10, 2018

Study Start

March 29, 2019

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations